Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at Leerink Partners believe that Merck’s Winrevair “should have ...

Merck MRK will report its fourth-quarter and full-year 2024 earnings on Feb. 4, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $15.56 billion and $1.72 per ...

On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...

Now there’s a new one for the list: cancer prevention vaccines. Merck, which makes the commonly used Gardasil shot, has shed 14 per cent of its market value since announcing last week that it ...

RAHWAY, N.J., January 28, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly ...

CHELMSFORD — A partial roof replacement project for South Row Elementary School in Chelmsford was accepted into the Massachusetts School Building Authority’s Accelerated Repair Program.

School administrators met on Jan. 29 with the Massachusetts School Building Authority’s Facility Assessment Subcommittee to review the project’s status. According to the Littleton announcement ...

WITH BREAKING NEWS. BREAKING NEWS. MULTIPLE FIRE DEPARTMENTS ARE WORKING TO PUT OUT A BIG STRUCTURE. FIRE IN MANNING. THAT’S OVER IN CARROLL COUNTY. TAKE A LOOK AT THESE PICTURES. IT IS MASSIVE.

LEOMINSTER — The city, in partnership with the Massachusetts School Building Authority (MSBA), is continuing to move forward with the Fall Brook Elementary School building project. The Fall ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical ...

Robert F. Kennedy Jr. is not qualified to be health and human services secretary for many reasons, chief among them being his years-long unscientific campaign against essential vaccines.

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.